Germ Cells Tumors - 22 Studies Found
| Completed |
: ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors : Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) : 2010-01-21 : Drug: Tivantinib (ARQ 197) Capsule, 120 mg, BID (360 mg), approximately 112 days |
| Recruiting |
: Germ Cell Tumor and Testicular Tumor DNA Registry :
: 2014-03-26 :
|